Volume Alert - OREX 5.68 Orexigen Therapeutics $OR
Post# of 68
Posted On: 11/12/2014 11:40:09 AM
Volume Alert - OREX 5.68 Orexigen Therapeutics $OREX Hit a high today of 5.76 Closing the day 10:30 at 5.68 +0.64 +12.70% With a day low of 5.01 and a total volume of 3,144,502.
OREX Recent Posts: http://investorshangout.com/Orexigen-Therapeu...REX-55007/
OREX Orexigen Therapeutics Recent Headline News
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 82.85 (+1.98), OREX: 6.02 (+0.98), PCMI: 8.60 (-0.30), CYAN: 5.92 (-0.14), ACHN: 13.28 (+0.80), TGTX: 13.04 (+0.13), AGIO: 88.12 (+6.21), LIOX: 5.36 (-0.07), SAJA: 6.25 (+0.65), PLNR: 7.05 (+0.24)
Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Uptrend Call Working As Orexigen Therapeutics Stock Rises 23.6% (OREX)
Comtex SmarTrend(R) - Tue Nov 11, 11:04AM CST
SmarTrend identified an Uptrend for Orexigen Therapeutics (NASDAQ:OREX) on October 17th, 2014 at $4.16. In approximately 4 weeks, Orexigen Therapeutics has returned 23.56% as of today's recent price of $5.14.
OREX: 6.02 (+0.98)
Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), AMAG: 34.70 (-0.18)
Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:25AM CST
Orexigen (OREX) was a big mover last session, with shares surging over 33% on the day.
BIIB: 319.78 (-4.81), OREX: 6.02 (+0.98), AMAG: 34.70 (-0.18), AFFX: 9.50 (+0.08)
Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Look for Shares of Orexigen Therapeutics to Potentially Pullback after Yesterday's 33.25% Rise
Comtex SmarTrend(R) - Mon Nov 10, 5:24PM CST
Orexigen Therapeutics (NASDAQ:OREX) traded in a range yesterday that spanned from a low of $4.04 to a high of $5.33. Yesterday, the shares gained 33.2%, which took the trading range above the 3-day high of $4.08 on volume of 15.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OREX: 6.02 (+0.98)
Market News: Apple,FireEye, Orexigen Therapeutics
at The Street - Mon Nov 10, 4:17PM CST
Oppenheimer market strategist, John Stoltzfus estimated that the S&P 500 could reach as 2,080 pointsThe stock markets in the United States ended the trading session higher as investors speculated that...
OREX: 6.02 (+0.98), FEYE: 32.66 (-0.19), AAPL: 110.63 (+0.93)
Dean Foods and Toll Brothers are big market movers
AP - Mon Nov 10, 3:48PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
DVAX: 16.15 (-0.45), OREX: 6.02 (+0.98), RYN: 26.31 (-0.42), MRK: 59.26 (-0.11), CMCSK: 53.27 (+0.49), DF: 16.48 (+0.21), TOL: 33.81 (+0.09), CMCSA: 53.41 (+0.45)
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
at The Street - Mon Nov 10, 1:53PM CST
Orexigen Therapeutics (OREX) stock is up after the company said the European Union review of its drug is progressing, as it reported better than expected third quarter earnings this morning.
OREX: 6.02 (+0.98)
Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 12:24PM CST
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:59AM CST
UCP: 11.43 (-0.27), JRJC: 7.40 (-0.09), NAVB: 1.01 (-0.01), SANW: 3.44 (-0.07), PLPM: 1.68 (-0.07), RYN: 26.31 (-0.42), INFU: 2.92 (-0.01), LIOX: 5.36 (-0.07), DY: 27.59 (-0.60), MTZ: 24.41 (-0.40), CGIX: 6.44 (-0.06), MUX: 1.38 (+0.04), OREX: 6.02 (+0.98), URRE: 2.46 (-0.05), ACHN: 13.28 (+0.80), REN: 2.58 (-0.12), MPO: 3.19 (+0.05), AKBA: 10.77 (+0.41), TRX: 1.09 (+0.03), PLNR: 7.05 (+0.24)
Stock to Watch: Orexigen Therapeutics Up 19.5% (OREX)
Comtex SmarTrend(R) - Mon Nov 10, 11:27AM CST
Orexigen Therapeutics (NASDAQ:OREX) is one of today's best performing low-priced stocks, up 19.5% to $4.60 on 1.1x average daily volume. Orexigen Therapeutics has traded 3.6 million shares thus far today, vs. average volume of 3.3 million shares per day. The stock has outperformed the Dow (19.5% to the Dow's 0.1%) and outperformed the S&P 500 (19.5% to the S&P's 0.3%) during today's trading.
OREX: 6.02 (+0.98)
Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:51AM CST
OREX: 6.02 (+0.98)
Orexigen ups earnings by 161% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:16AM CST
OREX: 6.02 (+0.98)
Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter Earnings Beat
at The Street - Mon Nov 10, 9:33AM CST
Orexigen Therapeutics (OREX) stock is skyrocketing this morning after the company posted higher than expected third quarter earnings.
OREX: 6.02 (+0.98)
Orexigen Beats The Street On Milestone Payments
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 8:21AM CST
OREX: 6.02 (+0.98)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:14AM CST
PT: 1.77 (+0.06), GPRO: 77.46 (+2.46), OREX: 6.02 (+0.98), GOGO: 18.75 (+0.56), JRJC: 7.40 (-0.09), UEC: 1.78 (-0.02), ACHN: 13.30 (+0.82), ARQL: 1.20 (+0.05), CMCM: 18.67 (+0.65), IBIO: 1.16 (+0.01), DF: 16.48 (+0.21)
Orexigen Therapeutics (OREX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:25AM CST
OREX: 6.02 (+0.98)
OREX Recent Posts: http://investorshangout.com/Orexigen-Therapeu...REX-55007/
OREX Orexigen Therapeutics Recent Headline News
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 82.85 (+1.98), OREX: 6.02 (+0.98), PCMI: 8.60 (-0.30), CYAN: 5.92 (-0.14), ACHN: 13.28 (+0.80), TGTX: 13.04 (+0.13), AGIO: 88.12 (+6.21), LIOX: 5.36 (-0.07), SAJA: 6.25 (+0.65), PLNR: 7.05 (+0.24)
Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Uptrend Call Working As Orexigen Therapeutics Stock Rises 23.6% (OREX)
Comtex SmarTrend(R) - Tue Nov 11, 11:04AM CST
SmarTrend identified an Uptrend for Orexigen Therapeutics (NASDAQ:OREX) on October 17th, 2014 at $4.16. In approximately 4 weeks, Orexigen Therapeutics has returned 23.56% as of today's recent price of $5.14.
OREX: 6.02 (+0.98)
Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), AMAG: 34.70 (-0.18)
Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:25AM CST
Orexigen (OREX) was a big mover last session, with shares surging over 33% on the day.
BIIB: 319.78 (-4.81), OREX: 6.02 (+0.98), AMAG: 34.70 (-0.18), AFFX: 9.50 (+0.08)
Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Look for Shares of Orexigen Therapeutics to Potentially Pullback after Yesterday's 33.25% Rise
Comtex SmarTrend(R) - Mon Nov 10, 5:24PM CST
Orexigen Therapeutics (NASDAQ:OREX) traded in a range yesterday that spanned from a low of $4.04 to a high of $5.33. Yesterday, the shares gained 33.2%, which took the trading range above the 3-day high of $4.08 on volume of 15.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OREX: 6.02 (+0.98)
Market News: Apple,FireEye, Orexigen Therapeutics
at The Street - Mon Nov 10, 4:17PM CST
Oppenheimer market strategist, John Stoltzfus estimated that the S&P 500 could reach as 2,080 pointsThe stock markets in the United States ended the trading session higher as investors speculated that...
OREX: 6.02 (+0.98), FEYE: 32.66 (-0.19), AAPL: 110.63 (+0.93)
Dean Foods and Toll Brothers are big market movers
AP - Mon Nov 10, 3:48PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
DVAX: 16.15 (-0.45), OREX: 6.02 (+0.98), RYN: 26.31 (-0.42), MRK: 59.26 (-0.11), CMCSK: 53.27 (+0.49), DF: 16.48 (+0.21), TOL: 33.81 (+0.09), CMCSA: 53.41 (+0.45)
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
at The Street - Mon Nov 10, 1:53PM CST
Orexigen Therapeutics (OREX) stock is up after the company said the European Union review of its drug is progressing, as it reported better than expected third quarter earnings this morning.
OREX: 6.02 (+0.98)
Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 12:24PM CST
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:59AM CST
UCP: 11.43 (-0.27), JRJC: 7.40 (-0.09), NAVB: 1.01 (-0.01), SANW: 3.44 (-0.07), PLPM: 1.68 (-0.07), RYN: 26.31 (-0.42), INFU: 2.92 (-0.01), LIOX: 5.36 (-0.07), DY: 27.59 (-0.60), MTZ: 24.41 (-0.40), CGIX: 6.44 (-0.06), MUX: 1.38 (+0.04), OREX: 6.02 (+0.98), URRE: 2.46 (-0.05), ACHN: 13.28 (+0.80), REN: 2.58 (-0.12), MPO: 3.19 (+0.05), AKBA: 10.77 (+0.41), TRX: 1.09 (+0.03), PLNR: 7.05 (+0.24)
Stock to Watch: Orexigen Therapeutics Up 19.5% (OREX)
Comtex SmarTrend(R) - Mon Nov 10, 11:27AM CST
Orexigen Therapeutics (NASDAQ:OREX) is one of today's best performing low-priced stocks, up 19.5% to $4.60 on 1.1x average daily volume. Orexigen Therapeutics has traded 3.6 million shares thus far today, vs. average volume of 3.3 million shares per day. The stock has outperformed the Dow (19.5% to the Dow's 0.1%) and outperformed the S&P 500 (19.5% to the S&P's 0.3%) during today's trading.
OREX: 6.02 (+0.98)
Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:51AM CST
OREX: 6.02 (+0.98)
Orexigen ups earnings by 161% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:16AM CST
OREX: 6.02 (+0.98)
Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 6.02 (+0.98), VVUS: 3.26 (-0.01), ARNA: 4.57 (+0.08)
Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter Earnings Beat
at The Street - Mon Nov 10, 9:33AM CST
Orexigen Therapeutics (OREX) stock is skyrocketing this morning after the company posted higher than expected third quarter earnings.
OREX: 6.02 (+0.98)
Orexigen Beats The Street On Milestone Payments
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 8:21AM CST
OREX: 6.02 (+0.98)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:14AM CST
PT: 1.77 (+0.06), GPRO: 77.46 (+2.46), OREX: 6.02 (+0.98), GOGO: 18.75 (+0.56), JRJC: 7.40 (-0.09), UEC: 1.78 (-0.02), ACHN: 13.30 (+0.82), ARQL: 1.20 (+0.05), CMCM: 18.67 (+0.65), IBIO: 1.16 (+0.01), DF: 16.48 (+0.21)
Orexigen Therapeutics (OREX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:25AM CST
OREX: 6.02 (+0.98)
(0)
(0)Orexigen Therapeutics (OREXQ) Stock Research Links
Scroll down for more posts ▼